Reaction
Respiratory Tract Inflammation reporting signals
As of the last recalculation, Respiratory Tract Inflammation appears in 462 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 113.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 32 | 113.6 | 113.9 |
| Thiotepa | 13 | 63.1 | 63.2 |
| Mepolizumab | 40 | 39.6 | 39.6 |
| Omalizumab | 62 | 37.7 | 37.7 |
| Budesonide And Formoterol Fumarate Dihydrate | 69 | 37.5 | 37.5 |
| Basiliximab | 9 | 35.1 | 35.2 |
| Fluticasone Furoate And Vilanterol Trifenatate | 19 | 24.8 | 24.8 |